Oral News and Research

RSS

Scientists explore chili pepper's effect to develop new drug candidate for pain

Biting into a chili pepper causes a burning spiciness that is irresistible to some, but intolerable to others. Scientists exploring the chili pepper's effect are using their findings to develop a new drug candidate for many kinds of pain, which can be caused by inflammation or other problems.

21 Aug 2014

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

The most common form of diabetes is sometimes referred to as metabolic diabetes, which is the diabetes most people are very familiar with, type 2 diabetes. This form of diabetes is most prevalent in people that are overweight or obese. Historically, it has been confined to adults or older patients but it has been on the rise as the global obesity problem has continued to worsen.

20 Aug 2014

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

iCo Therapeutics Inc., today reported results of its Oral Amphotericin B (Oral Amp B) drug candidate targeting latent HIV reservoirs.

19 Aug 2014

Presence of Listeria monocytogenes in foods may cause abortions, meningitis

The results of the research conducted in the ICAS Culiacán reveal that at least 10 percent of the fresh cheese, sausages and meats sold in markets and on the street may be contaminated.

19 Aug 2014

Doctors test device designed to 'turn off' cluster headaches

For those suffering excruciating pain from cluster headaches, relief may soon be available from an investigational device being studied in a national multicenter clinical trial. Recently, doctors at The Ohio State University Wexner Medical Center performed the first surgery in the United States to insert a neurostimulator to provide relief from cluster headaches, which are more painful than migraines.

19 Aug 2014

Efforts to prevent prescription drug misuse among adults need to consider peers, not peer pressure

Current efforts to prevent prescription drug misuse among young adults need to consider peers - but not peer pressure - according to a Purdue University study.

18 Aug 2014

Physiological variables best predict adult asthma phenotypes

Physiological variables are more consistent predictors of adult asthma phenotypes than inflammatory biomarkers, an international team of researchers suggests.

13 Aug 2014

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Synthetic Biologics, Inc. (NYSE MKT: SYN), a biotechnology company developing novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and diseases, announced today that it will host an Investor Day in New York to discuss the Company's irritable bowel syndrome (IBS) program, including its novel, oral product SYN-010, targeting constipation-predominant IBS (C-IBS).

13 Aug 2014

Supermint fluoride toothpaste receives American Dental Association Seal of Acceptance

Hello is thrilled to announce that its supermint fluoride toothpaste has officially been awarded the American Dental Association (ADA) Seal of Acceptance. Recognized by dentists and consumers alike as the gold standard for U.S. oral care, the seal acknowledges that the product has met ADA guidelines for fluoride-containing toothpaste used for the control of tooth decay.

13 Aug 2014

Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.

13 Aug 2014

Researchers examine why older adults are at risk for malnutrition

More than half of older adults who visit emergency departments are either malnourished or at risk for malnutrition, but not because of lack of access to health care, critical illness or dementia.

13 Aug 2014

Research hopes to protect hundreds of newborns from severe health problems by protein in milk

An international effort led by the University of Sydney hopes to protect hundreds of Bangladeshi newborns from a host of severe health problems by assessing the effect of lactoferrin, a natural protein found in breast and cow's milk, in the treatment of iron deficiency anemia in pregnancy.

13 Aug 2014

Researchers identify predictors of early rehospitalization among patients with COPD

Researchers at the University of Texas Medical Branch at Galveston have identified predictors of early rehospitalization among patients hospitalized for complications of chronic obstructive pulmonary disease. This study was recently published in the Annals of the American Thoracic Society.

13 Aug 2014

ChromaDex reports 42% increase in Q2 2014 net sales

ChromaDex Corp., an innovative natural products company that provides proprietary, ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, announced today the financial results for the quarter ended June 28, 2014.

12 Aug 2014

Synthetic Biologics' SYN-005 antibody for Pertussis treatment to be highlighted at ICAAC 2014

Synthetic Biologics, Inc., a biotechnology company developing novel anti-infective biologic and drug programs targeting specific pathogens that cause serious infections and diseases, announced today that its SYN-005 for the treatment of Pertussis will be highlighted at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, September 5-9, in Washington D.C.

12 Aug 2014

Researchers discover how arginine starvation specifically kills cancer cells

Researchers at UC Davis, City of Hope, Taipai Medical University and National Health Research Institutes in Taiwan have discovered how a drug that deprives the cells of a key amino acid specifically kills cancer cells.

12 Aug 2014

Patients recovering from total joint replacement surgery who receive AAT require less pain drugs

Patients recovering from total joint replacement surgery who receive animal-assisted therapy (AAT) require less pain medication than those who do not experience this type of therapy.

8 Aug 2014

Dentist educates patients about sedation dentistry

The American Dental Association estimates that as much as 10 percent of the American population have dental phobia. Dental phobia is a severe anxiety or dread of making a trip to the dentist.

7 Aug 2014

Access Pharmaceuticals enters into exclusive license agreement with Norgine

ACCESS PHARMACEUTICALS, INC., an emerging biopharmaceutical company, today announced that it had entered into an exclusive license agreement with Norgine B.V., a leading independent European specialty pharmaceutical company, for the commercialization of MuGard in Europe.

7 Aug 2014

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

CTI BioPharma Corp. announced today that pacritinib has been granted Fast Track designation by the U.S. Food and Drug Administration for the treatment of intermediate and high risk myelofibrosis, including but not limited to patients with disease related thrombocytopenia, patients experiencing treatment emergent thrombocytopenia on other JAK2 therapy or patients who are intolerant to or whose symptoms are sub-optimally managed on other JAK2 therapy.

7 Aug 2014

Oral News and Research

Scientists explore chili pepper's effect to develop new drug candidate for pain

Using a nanotech microchip to diagnose type 1 diabetes: an interview with Dr. Brian Feldman, Stanford School of Medicine

iCo reports study results of Oral Amp B drug candidate targeting latent HIV reservoirs

Presence of Listeria monocytogenes in foods may cause abortions, meningitis

Doctors test device designed to 'turn off' cluster headaches

Efforts to prevent prescription drug misuse among adults need to consider peers, not peer pressure

Physiological variables best predict adult asthma phenotypes

Synthetic Biologics hosts Investor Day to discuss irritable bowel syndrome program

Supermint fluoride toothpaste receives American Dental Association Seal of Acceptance

Tarsa obtains $10 million senior credit facility to support NDA submission for Ostora tablet

Researchers examine why older adults are at risk for malnutrition

Research hopes to protect hundreds of newborns from severe health problems by protein in milk

Researchers identify predictors of early rehospitalization among patients with COPD

ChromaDex reports 42% increase in Q2 2014 net sales

Synthetic Biologics' SYN-005 antibody for Pertussis treatment to be highlighted at ICAAC 2014

Researchers discover how arginine starvation specifically kills cancer cells

Patients recovering from total joint replacement surgery who receive AAT require less pain drugs

Dentist educates patients about sedation dentistry

Access Pharmaceuticals enters into exclusive license agreement with Norgine

CTI BioPharma's pacritinib granted FDA Fast Track designation for treatment of myelofibrosis

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News